Australia invests $13.3m in commercialising digital health research

Six companies will receive a share of $2.5m (A$3.75m) to develop medical technologies. 

The Australian government has announced an investment of $13.3m (A$20m) to commercialise digital health research on neurological disorders such as multiple sclerosis and dementia.

The investment will support six companies that are set to receive a share of $2.5m (A$3.75m) funding from the government as part of a programme run by ANDHealth+ to support early-stage development of technologies with commercial potential.

In line with this, ANDHealth+ received approximately $13.1m (A$19.75m) through the Medical Research Future Fund’s (MRFF) Medical Research Commercialisation initiative.

“These investments will support Australia’s highest-potential digital health innovators to navigate the complex and evolving landscape of digital health commercialisation, providing hands-on support and access to leading experts from around the globe.” ANDHealth+ CEO, Bronwyn Le Grice, said.

Currently, the MRFF investment has supported 21 companies in their research for digital health solutions.

(A$1 = US$0.66)